The Role of Probiotic and Prebiotic Supplementation on Semen Parameters in Idiopathic Male Infertility: A Narrative Review
DOI:
https://doi.org/10.29303/jk.v15i2.8961Keywords:
Probiotic, Prebiotic, Semen, Infertility, Idiopathic, Narrative, ReviewAbstract
Male factors are the most prevalent cause for infertility in the world. The "gut-testis axis" theory posits that oxidative stress, systemic inflammation, and dysbiosis of the gut and seminal microbiomes are the primary etiological factors. This review focused on clarifying the efficacy of probiotic and prebiotic supplements on the semen of men who experience idiopathic infertility. We searched through PubMed (n=82), Scopus (n=71), and the Cochrane Library (n=33) between January 2020 and 2025. The search focused on randomized controlled trials (RCTs) and mechanistic research on Lactobacillus, Bifidobacterium, fructooligosaccharides (FOS), and synbiotics in human subjects or animal models. Total of 22 included studies involved human subjects, while 9 were based on animal models. Synbiotic therapy, such as Lactobacillus strains combined with FOS significantly enhance sperm concentration, progressive motility, and normal morphology compared to a placebo. These medications reduced the levels of CRP and TNF-α, which are signs of systemic inflammation. These therapies also reduce the levels of seminal lipid peroxidation and sperm DNA fragmentation (SDF). Recent findings show that using both synbiotics and antioxidants together is significantly better than using only antioxidants. Probiotic and prebiotic supplementation represents a promising, low-risk adjunctive therapy for idiopathic male infertility by restoring the gut-testis axis, ameliorating oxidative stress, and improving sperm functional integrity.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Muhammad Sultan Ardhi Pratama Firdausy

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with Unram Medical Journal, agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC-BY License). This license allows authors to use all articles, data sets, graphics, and appendices in data mining applications, search engines, websites, blogs, and other platforms by providing an appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in University of Mataram's Journal of Medicine.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- This journal is open access journal which means that all content is freely available without charge to users or / institution. Users are allowed to read, download, copy, distribute, print, search, or link to full text articles in this journal without asking prior permission from the publisher or author.








